Citation Tools

HPV16 LONG PEPTIDE VACCINE IS SAFE AND INDUCES STRONG TYPE 1 T-CELL IMMUNITY IN PATIENTS WITH END-STAGE CERVICAL CANCER

Download to a citation manager

Cite this article as:
Welters MJ, van de Burg SH, Lowik MJ, et al
HPV16 LONG PEPTIDE VACCINE IS SAFE AND INDUCES STRONG TYPE 1 T-CELL IMMUNITY IN PATIENTS WITH END-STAGE CERVICAL CANCER